Single EU patent court delayed ‘until 2016 or beyond’ as jurisdiction amended
This article was originally published in Scrip
The European Commission is planning to update the legislation on court jurisdiction and the recognition of judgments in order to allow the future Unified Patent Court to enter into force as soon as possible. But the upshot of this enabling measure is that the Court is unlikely to be operational until 2016 or beyond, as the national and internecine politics play out.
You may also be interested in...
The US company is bringing extra supplies of lopinavir/ritonavir into France but stresses that the combination treatment is not authorized for treating patients with the coronavirus.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.